Gut Microbiota Dynamics in Organ Transplantation

The interplay between the gut microbial community and host immunity has emerged as a critical determinant of transplant outcomes. Following organ transplantation, recipients experience profound shifts in microbial diversity and composition driven by immunosuppressive regimens, peri-operative antibiotics and physiological stress. Such dysbiosis can exacerbate systemic inflammation, promote allograft rejection and increase susceptibility to infection. Conversely, a stable and diverse microbiota contributes to regulatory immune pathways, enhances barrier function and modulates the pharmacokinetics of key immunosuppressants. Integrative metagenomic and metabolomic approaches have begun to identify specific microbial signatures and metabolites that predict clinical trajectories. Non-invasive faecal monitoring offers a window into patient status, enabling tailored interventions—such as prebiotic or probiotic supplementation and antimicrobial stewardship—to support graft longevity and improve patient quality of life on a global scale.

Research from Nature Portfolio

Recent work in kidney transplant recipients has revealed a tight association between gut microbiome composition and health-related quality of life. In a large cohort, reduced microbial resemblance to healthy controls correlated with impaired physical and mental well-being. Analyses of metabolic and neuroactive pathways further linked specific microbial communities to aspects of the gut-brain axis, suggesting that restoration of a balanced microbiota could enhance post-transplant recovery.

Foundational studies have explored how long-term immunosuppressive therapy alters gut metagenomic profiles and contributes to post-transplant diabetes. In an animal model, tacrolimus and sirolimus induced a catabolic microbial shift with loss of beneficial taxa and enrichment of pathways involved in sugar degradation. Probiotic treatment reversed these changes, highlighting the potential for microbiome modulation to mitigate metabolic complications.

Gut Microbiota Dynamics in Organ Transplantation publication trend

The graph below shows the total number of articles in gut microbiota dynamics in organ transplantation across all publications each year (not limited to Nature Index journals).

Technical terms

Gut microbiota: The collection of microorganisms, including bacteria, archaea, viruses and fungi, residing in the gastrointestinal tract.

Allograft rejection: Immune-mediated injury leading to loss of function of a transplanted organ from the same species but genetically distinct donor.

Dysbiosis: Disruption or imbalance in the composition and function of the microbial community.

Metagenomic sequencing: High-throughput analysis of genetic material recovered directly from environmental samples to characterise community structure and function.

Alpha diversity: A measure of species richness and evenness within a single microbial community sample.

Pharmacokinetics: Study of the absorption, distribution, metabolism and excretion of drugs within the body.

Bacterial translocation: Passage of viable bacteria from the gastrointestinal tract across the mucosal barrier into normally sterile tissues or the bloodstream.

ABCB1 (P-glycoprotein): An ATP-binding cassette efflux transporter expressed in intestinal epithelium that influences drug absorption and systemic exposure.

References

1. Health-related quality of life is linked to the gut microbiome in kidney transplant recipients. Nature Communications (2023).
2. Impact of Immunosuppression on the Metagenomic Composition of the Intestinal Microbiome: a Systems Biology Approach to Post-Transplant Diabetes. Scientific Reports (2017).
3. Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study. Signal Transduction and Targeted Therapy (2023).
4. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome (2023).
5. A metagenomic prospective cohort study on gut microbiome composition and clinical infection in small bowel transplantation. Gut Microbes (2024).